期刊文献+

骨肉瘤干细胞研究进展 被引量:2

原文传递
导出
摘要 肿瘤的组织结构多种多样,其中间质成分起支持和营养作用,实质是肿瘤的主要成分,决定肿瘤的生物学特点.通常根据肿瘤的实质形态来识别肿瘤的组织来源,并根据其分化成熟程度和异型性大小来确定肿瘤的恶性程度.随着对肿瘤实质细胞研究的深入,科学家发现其中含量较少的部分实质细胞与干细胞在表面标志和生物学特性上有很多相似之处,具有特殊的生物学行为,与肿瘤的生长、转移、耐药和复发关系密切,并由此推断肿瘤是由干细胞增殖分化失调引起,并提出了肿瘤干细胞(cancer stem cell,CSC)这一概念[1].
出处 《中国骨肿瘤骨病》 2011年第2期188-191,共4页 Chinse Journal Of Bone Tumor And Bone Disease
基金 国家自然基金(编号:30872641 30901525)
  • 相关文献

参考文献37

  • 1Reya T,Morrison SJ,Clarke MF,et al.Stem cells,cancer,and cancer stem cells.Nature,2001,414:105-111.
  • 2Dalerba P,Cho RW,Clarke MF.Cancer stem cells:models and concepts.Annu Rev Med,2007,58:267-284.
  • 3Hiyama E,Hiyama K.Telomere and telomerase in stem cells.Br J Cancer,2007,96:1020-1024.
  • 4Sell S.Cancer cell and stem cell signaling:a guide to preventive and therapeutic strategies for cancer stem cells.Stem Cell Bev,2007,3:1-6.
  • 5Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.Nature Med,1997,3:730-737.
  • 6Donnenberg VS,Donnenberg AD.Multipl e drag resistance in cancer revisited the cancer stem cell hypothesis.Clin Pharmacol,2005,45:872-877.
  • 7Chaichana K,Zamora-Berridi G,Camara-Quintana J,et al.Neurosphere assays:growth factors and hormone differences in tumor and nontumor studies.Stem Cells,2006,24:2851-2857.
  • 8Cox CV,Evely RS,Oakhill A,et al.Characterization of acute lymphoblastic leukemia progenitor cells.Blood,2004,104:2919-2925.
  • 9Du X,Ho M,Pastan I.New immunotoxins targeting CD123,a stem cell antigen on acute myeloid leukemia cells.J Immunother,2007,30:607-613.
  • 10Hosen N,Park CY,Tatsumi N,et al.CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia.Prec Natl Acad Sci USA,2007,104:11008-11013.

同被引文献55

  • 1欧阳振,王栓科,康学文,王翠芳,汪静,郭洪章.人骨肉瘤细胞株U2-OS中分离并鉴定肿瘤干细胞[J].中国组织工程研究与临床康复,2007,11(24):4706-4709. 被引量:6
  • 2Tang N,Song WX,Luo J. Osteosarcoma development and stem cel differentiation[J].Clinical Orthopaedics and Related Research,2008,(09):2114-2130.doi:10.1007/s11999-008-0335-z.
  • 3Lewis IJ,Nooij MA,Whelan J. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy:a randomized phase III trial of the European Osteosarcoma Intergroup[J].JOURNAL OF THE NATIONAL CANCER INSTITUTE,2007,(02):112-128.doi:10.1093/jnci/djk015.
  • 4Meyers PA,Schwartz CL,Krailo MD. Osteosarcoma:the addition of muramyl tripeptide to chemotherapy improves overal survival--a report from the Children's Oncology Group[J].Journal of Clinical Oncology,2008,(04):633-638.doi:10.1200/JCO.2008.14.0095.
  • 5Kansara M,Thomas DM. Molecular pathogenesis of osteosarcoma[J].DNA Cel Biol,2007,(01):1-18.
  • 6Pittenger MF,Mackay AM,Beck SC. Multilineage potential of adult human mesenchymal stem cel s[J].SCIENCE,1999,(5411):143-147.doi:10.1126/science.284.5411.143.
  • 7Wang L,Park P,Lin CY. Characterization of stem cel attributes in human osteosarcoma cel lines[J].CANCER BIOLOGY & THERAPY,2009,(06):543-552.
  • 8Tirino V,Desiderio V,d'Aquino R. Detection and characterization of CD133+ cancer stem cel s in human solid tumours[J].PLoS One,2008,(10):e3469.
  • 9Gibbs CP,Kukekov VG,Reith JD. Stem-like cel s in bone sarcomas:implications for tumorigenesis[J].Neoplasia,2005,(11):967-976.
  • 10Lapidot T,Sirard C,Vormoor J. A cel initiating human acute myeloid leukaemia after transplantation into SCID mice[J].NATURE,1994,(6464):645-648.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部